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LETTER TO EDITOR
MOLECULAR EPIDEMIOLOGY OF A MEASLES VIRUS IN SAO PAULO, BRAZIL: AN IMPORTED CASE
Sao Paulo, March 27, 2013
Dear Sir,
Brazil follows the recommendations of the World Health Organization 
concerning the use of several strategies of measles vaccination programs 
and has succeeded in reducing transmission of the wild-type viruses. Sao 
Paulo State follows the same pattern; however, there was circulation of 
an imported case of virus in 2001 and 2005, which was shown to belong 
to the D5 group and in 2011 to the D4 group3. In 2012 there were no 
reports of confirmed measles cases.
In Sao Paulo on 12.23.2012, Epidemiological Surveillance Center 
notified a suspected case of measles virus of a 20-year-old male, living in 
the city of Bauru/SP, with a history of international travel to Florida, USA. 
The patient had previously received two doses of measles vaccine. When 
returning to SP/Brazil he presented the first symptoms on 12.25.2012, 
with fever followed by rash, cough, coryza, conjunctivitis, diarrhea and 
prostration. Samples were collected on 01.02.2013. The Adolfo Lutz 
Institute (SP) processed samples by using ELISA assay measles-specific 
immunoglobulin (IgM/IgG) and Real Time PCR assays, which confirmed 
the presence of measles virus. 
Phylogenetic analysis of measles virus wild type strain has been used 
to trace the routes of transmission and circulation. We used the region 
encoding the nucleoprotein (N), that presents variability from 7% to 
12% among wild-type viruses. For molecular epidemiology, genotype 
designations are considered the operational taxonomic unit, while related 
genotypes are grouped by eight clades designated A, B, C, D, E, F, G and 
H. Within these clades, there are 23 recognized genotypes6.
Our result indicated that the virus was a member of genotype D8. This 
patient had contact with two persons, a 20-year-old female and a 13-year-
old male who had previously received two doses of measles vaccine, and 
who received a third dose on 01.02.2013, developing measles symptoms 
on 01.08.2013. Samples were collected on 01.11.2013. Results showed 
IgM no reagent and IgG reagent for the two patients’ contacts. Real 
Time PCR assay confirmed measles virus and sequencing was processed 
showing Genotype D8. This genotype has circulated in England and has 
been detected in other countries including the USA, Canada and China2,4,7. 
Although patients had received two doses of vaccine, several obstacles 
to eradicate measles should be considered such as the persistent infection 
with transmissible measles virus which poses a biological barrier to its 
eradication5. However, such cases should always be monitored to assure 
that contacts remain uninfected1. The air travelling passengers were also 
contacted to initiate preventive measures against the virus.
To maintain good measles control, children should be vaccinated 
against measles at the right time through routine childhood immunization; 
likewise, all young adults who travel internationally should be vaccinated 
as well. Clinician awareness remains important for the early identification 
and control of measles to avoid further transmission during outbreaks and 
to enable the timely implementation of public health measures.
We thank Paul A. Rota, Division of Viral Diseases, Centers for 
Disease Control and Prevention, Atlanta, GA, USA, by protocol for the 
test-Real Time PCR.
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